Durable responses to treatment, with a median duration of response (mDoR) of 11.7 months, reported in Phase 1b/2 clinical trial of onvansertib plus FOLFIRI/bevacizumab in second-line KRAS-mutated mCRC

Analysis Evaluates Efficacy of Eribulin in Metastatic HER2-low Breast Cancer Across Three Studies (Presentation: #259P) NUTLEY, N.J., Sept. 10, 2022 /PRNewswire/ -- Eisai announced today results...

Multi-Biomarker Approach Achieves 61 Percent Sensitivity for Cancer at an Overall Specificity of 98.2 Percent in Robust Case-Control Study Including Nearly 600 Cancer Samples Data will Inform the...

Aktiia leveraged its data set of more than 55m data points to demonstrate that hypertensive individuals who use the Aktiia 24/7 cuffless monitor persistently for six months achieve a significant...

NICB President and CEO David Glawe to meet with IASIU President Celeste Dodson during IASIU Annual Conference SAN DIEGO, Sept. 9, 2022 /PRNewswire/ -- The National Insurance Crime Bureau (NICB),...

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced...

On September 5th, the World Winter Sports (Beijing) Expo 2022 (hereinafter referred to as the "WWSE"), co-hosted by Asia Digital Group, was concluded in Shougang Park, Beijing. Since its inception...

Thumper Fab announced it would be bringing a whole fleet of customized off-road vehicles, tricked-out rides, and gearhead goodies for display in the legendary SEMA show from November 1-4 in Las...

Leading Neurology Faculty to Present Clinical Updates and Management Strategies for Key Neurological Conditions NEW YORK, Sept. 9, 2022 /PRNewswire/ -- Medscape Education will host the inaugural...

Prologis, Inc. (NYSE: PLD), the global leader in logistics real estate, today announced that Tim Arndt, chief financial officer, will participate in two conferences in New York City: Barclays 2022...